S&P 500   4,274.04
DOW   33,980.32
QQQ   328.49
Agilent Technologies Proves Its Worth VS Illumina 
Massive Supercycle Investment Opportunities for 2022-2027 (Ad)pixel
Target’s Results Cap Upside Potential For Retail Stocks 
Wind energy boom and golden eagles collide in the US West
Lowe’s Stands Out Amid Q2 Retail Reports 
Massive Supercycle Investment Opportunities for 2022-2027 (Ad)pixel
Egypt's central bank governor resigns as economic woes mount
Target takes a hit after heavy discounts to clear inventory
Stocks slip on Wall Street, erasing weekly gains for S&P 500
Bargain in Today's Market (SHOCKING) (Ad)pixel
S&P 500   4,274.04
DOW   33,980.32
QQQ   328.49
Agilent Technologies Proves Its Worth VS Illumina 
Massive Supercycle Investment Opportunities for 2022-2027 (Ad)pixel
Target’s Results Cap Upside Potential For Retail Stocks 
Wind energy boom and golden eagles collide in the US West
Lowe’s Stands Out Amid Q2 Retail Reports 
Massive Supercycle Investment Opportunities for 2022-2027 (Ad)pixel
Egypt's central bank governor resigns as economic woes mount
Target takes a hit after heavy discounts to clear inventory
Stocks slip on Wall Street, erasing weekly gains for S&P 500
Bargain in Today's Market (SHOCKING) (Ad)pixel
S&P 500   4,274.04
DOW   33,980.32
QQQ   328.49
Agilent Technologies Proves Its Worth VS Illumina 
Massive Supercycle Investment Opportunities for 2022-2027 (Ad)pixel
Target’s Results Cap Upside Potential For Retail Stocks 
Wind energy boom and golden eagles collide in the US West
Lowe’s Stands Out Amid Q2 Retail Reports 
Massive Supercycle Investment Opportunities for 2022-2027 (Ad)pixel
Egypt's central bank governor resigns as economic woes mount
Target takes a hit after heavy discounts to clear inventory
Stocks slip on Wall Street, erasing weekly gains for S&P 500
Bargain in Today's Market (SHOCKING) (Ad)pixel
S&P 500   4,274.04
DOW   33,980.32
QQQ   328.49
Agilent Technologies Proves Its Worth VS Illumina 
Massive Supercycle Investment Opportunities for 2022-2027 (Ad)pixel
Target’s Results Cap Upside Potential For Retail Stocks 
Wind energy boom and golden eagles collide in the US West
Lowe’s Stands Out Amid Q2 Retail Reports 
Massive Supercycle Investment Opportunities for 2022-2027 (Ad)pixel
Egypt's central bank governor resigns as economic woes mount
Target takes a hit after heavy discounts to clear inventory
Stocks slip on Wall Street, erasing weekly gains for S&P 500
Bargain in Today's Market (SHOCKING) (Ad)pixel
NASDAQ:APDN

Applied DNA Sciences - APDN Earnings Date, Estimates & Call Transcripts

$3.71
+0.38 (+11.41%)
(As of 08/17/2022 12:00 AM ET)
Add
Compare
Today's Range
$3.05
$3.71
50-Day Range
$0.68
$5.83
52-Week Range
$0.62
$7.35
Volume
2.54 million shs
Average Volume
2.81 million shs
Market Capitalization
$44.46 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$5.00

Earnings Summary

Upcoming
Earnings Date
Dec. 8Estimated
Actual EPS
(Aug. 11)
-$0.13 Beat By $0.19
Consensus EPS
(Aug. 11)
-$0.32
Skip Charts & View Estimated and Actual Earnings Data

APDN Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

APDN Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Applied DNA Sciences Analyst Forecasts

Current Year EPS Consensus Estimate: $-1.49 EPS
Next Year EPS Consensus Estimate: $-0.68 EPS

APDN Earnings Date and Information

Applied DNA Sciences last issued its quarterly earnings data on August 11th, 2022. The technology company reported ($0.13) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.32) by $0.19. Applied DNA Sciences has generated ($1.59) earnings per share over the last year (($1.59) diluted earnings per share). Earnings for Applied DNA Sciences are expected to grow in the coming year, from ($1.49) to ($0.68) per share. Applied DNA Sciences has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, December 8th, 2022 based off prior year's report dates.

Applied DNA Sciences Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
12/8/2022
(Estimated)
        
8/11/2022Q3($0.32)($0.13)+$0.19  
5/12/2022Q2 2022($0.30)($0.28)+$0.02($0.33)$4.65 million$6.15 million
2/10/2022Q1 2022($0.19)($0.63)($0.44)($0.63)$4.28 million$4.17 million    
12/9/2021Q4 2021($0.32)($0.49)($0.17)($0.38)$2.84 million$3.00 million
8/11/20216/30/2021($0.26)($0.46)($0.20)($0.46)$3.44 million$1.70 million    
5/12/20213/31/2021($0.21)($0.33)($0.12)($0.45)$2.62 million$2.67 million  
2/10/202112/31/2020($0.54)($0.56)($0.02)($0.36)$1.40 million$1.62 million  
12/16/20209/30/2020($0.52)($0.78)($0.26)($0.82)$0.70 million$0.31 million  
8/6/20206/30/2020($0.62)($0.72)($0.10)($0.72)$0.50 million$0.43 million  
5/14/20203/31/2020($0.77)($0.79)($0.02)($0.79)$0.55 million  
2/6/2020Q1 2020($1.24)($1.1197)+$0.1203($1.12)$0.63 million  
12/12/2019Q4 2019($1.26)($2.63)($1.37)($1.44)$1.70 million  
8/13/2019Q3 2019($0.06)($0.0388)+$0.0212($0.04)$2.05 million  
5/9/2019Q2($0.09)($0.08)+$0.01($0.08)$0.78 million  
2/7/201912/31/2018($0.08)($0.1060)($0.0260)($0.11)$0.88 million
12/13/2018Q4 2018($0.04)($0.12)($0.08)($0.12)$1.20 million
8/13/2018Q3 2018($0.05)($0.0960)($0.0460)($0.10)$1.02 million
5/3/2018Q2 2018($0.12)($0.07)+$0.05($0.07)$1.04 million
2/8/2018Q1 2018($0.12)($0.12)($0.12)$0.65 million
12/28/2017Q4 2017($0.10)($0.10)($0.10)$1.15 million  
8/10/2017Q3 2017($0.14)($0.10)+$0.04($0.10)$2.18 million$1.80 million
5/11/2017Q2 2017($0.14)($0.13)+$0.01($0.13)$1.25 million$0.91 million
2/9/2017Q117($0.06)($0.16)($0.10)($0.16)$1.66 million$0.70 million  
12/6/2016Q416($0.09)($0.10)($0.01)($0.10)$4.98 million$1.60 million  
8/11/2016Q316($0.11)($0.14)($0.03)($0.14)$1.47 million$0.65 million  
5/12/2016Q216($0.10)($0.14)($0.04)($0.14)$1.60 million$0.60 million  
2/10/2016Q116($0.07)($0.13)($0.06)($0.13)$2.04 million$1.32 million  
12/14/2015Q415($0.12)($0.02)+$0.10($0.02)$2.09 million$3.98 million  
8/10/2015Q315($0.13)($0.08)+$0.05($0.08)$1.45 million$2.30 million  
5/11/2015Q215($0.19)($0.11)+$0.08($0.11)$1.30 million$1.50 million
2/9/2015Q1 2015($0.18)($0.25)($0.07)$0.01$1.00 million$1.24 million
12/15/2014Q4 2014($0.18)($0.16)+$0.02($0.16)$0.95 million$0.65 million
2/10/2014Q1 2014($0.60)($0.60)($0.60)$0.85 million$0.60 million
2/14/2013Q1 2013($0.60)($0.60)($0.60)
8/14/2012Q3 2012($0.12)($0.12)($0.12)
5/15/2012Q2 2012($0.60)($0.18)+$0.42($0.18)
12/9/2011Q4 2011($0.60)($0.60)($0.60)
8/10/2011Q3 2011($0.36)($0.36)($0.36)
5/16/2011Q2 2011($0.42)($0.42)($0.42)
2/17/2009Q1 2009($0.60)($0.60)($0.60)












Applied DNA Sciences Earnings - Frequently Asked Questions

When is Applied DNA Sciences's earnings date?

Applied DNA Sciences has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, December 8th, 2022 based off last year's report dates. Learn more on APDN's earnings history.

Did Applied DNA Sciences beat their earnings estimates last quarter?

In the previous quarter, Applied DNA Sciences (NASDAQ:APDN) reported ($0.13) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.32) by $0.19. Learn more on analysts' earnings estimate vs. APDN's actual earnings.

How can I listen to Applied DNA Sciences's earnings conference call?

The conference call for Applied DNA Sciences's latest earnings report can be listened to online. Listen to Conference Call

How much revenue does Applied DNA Sciences generate each year?

Applied DNA Sciences (NASDAQ:APDN) has a recorded annual revenue of $9.03 million.

How much profit does Applied DNA Sciences generate each year?

Applied DNA Sciences (NASDAQ:APDN) has a recorded net income of -$14.29 million. APDN has generated -$1.59 earnings per share over the last four quarters.

What is Applied DNA Sciences's EPS forecast for next year?

Applied DNA Sciences's earnings are expected to grow from ($1.49) per share to ($0.68) per share in the next year.

More Earnings Resources from MarketBeat

Upcoming Earnings:
This page (NASDAQ:APDN) was last updated on 8/18/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.